Template:Butalbital/aspirin/caffeine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine|{{fontcolor|#6C7B8B| | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine|{{fontcolor|#6C7B8B|Butalbital/aspirin/caffeine}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet <sup>®</sup> FDA Package Insert | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet <sup>®</sup> FDA Package Insert | ||
Latest revision as of 04:08, 12 February 2014
| Butalbital/aspirin/caffeine |
|---|
| BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet ® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital/aspirin/caffeine |
| ClinicalTrials.gov |